Influence of reaction medium during synthesis of Gantrez® AN 119 nanoparticles for oral vaccination

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 74, Issue 2, 2010, Pages 202-208

  Vandamme, Katrien ^a   Melkebeek, Vesna ^a   Cox, Eric ^a   Deforce, Dieter ^a   Lenoir, Joke ^a   Adriaens, Els ^a   Vervaet, Chris ^a   Remon, Jean Paul ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Adjuvant; Gantrez AN 119; Nanoparticles; Oral antigen delivery; Poly(methyl vinyl ether co maleic anhydride); Slug mucosal irritation assay; WGA

Indexed keywords

1,3 PROPANEDIAMINE; ACETONE; BETA GALACTOSIDASE; GANTREZ COPOLYMER; NANOPARTICLE; STOMACH MUCIN; VACCINE; WHEAT GERM AGGLUTININ;

ARTICLE; BIOCOMPATIBILITY; CHEMICAL BOND; CONTROLLED STUDY; CROSS LINKING; DRUG COATING; DRUG STABILITY; DRUG SYNTHESIS; HYDROLYSIS; INTERMETHOD COMPARISON; LIGAND BINDING; MUCOSA INFLAMMATION; NANOENCAPSULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRECIPITATION; PROTEIN BINDING; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; BETA-GALACTOSIDASE; DIAMINES; DRUG CARRIERS; DRUG STABILITY; GASTROPODA; MALEATES; MALEIC ANHYDRIDES; METHYL ETHERS; MUCUS; NANOPARTICLES; POLYVINYLS; PROTEIN BINDING; VACCINATION; WHEAT GERM AGGLUTININS;

EID: 75449119643     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.10.001     Document Type: Article

References (30)

1. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12 5 (1994) 387-400
2. O'Hagan D.T. Microparticles and polymers for the mucosal delivery of vaccines. Advanced Drug Delivery Reviews 34 2-3 (1998) 305-320
3. Clark M.A., Jepson M.A., and Hirst B.H. Exploiting M cells for drug and vaccine delivery. Advanced Drug Delivery Reviews 50 1-2 (2001) 81-106
4. Lavelle E.C. Lectins and microparticles for enhanced oral vaccination. Methods 38 2 (2006) 84-89
5. Sakuma S., Hayashi M., and Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Advanced Drug Delivery Reviews 47 1 (2001) 21-37
6. Murillo M., Goni M.M., Irache J.M., Arangoa M.A., Blasco J.M., and Gamazo C. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. Journal of Controlled Release 85 1-3 (2002) 237-246
7. Arbos P., Wirth M., Arangoa M.A., Gabor F., and Irache J.M. Gantrez (R) AN as a new polymer for the preparation of ligand-nanoparticle conjugates. Journal of Controlled Release 83 3 (2002) 321-330
8. Arbos P., Campanero M.A., Arnangoa M.A., Renedo M.J., and Irache J.M. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. Journal of Controlled Release 89 1 (2003) 19-30
9. Gomez S., Gamazo C., Roman B.S., Vauthier C., Ferrer M., and Irache J.M. Development of a novel vaccine delivery system based on Gantrez nanoparticles. Journal of Nanoscience and Nanotechnology 6 9-10 (2006) 3283-3289
10. Salman H.H., Gamazo C., Campanero M.A., and Irache J.M. Salmonella-like bioadhesive nanoparticles. Journal of Controlled Release 106 1-2 (2005) 1-13
11. Arbos P., Arangoa M.A., Campanero M.A., and Irache J.M. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. International Journal of Pharmaceutics 242 1-2 (2002) 129-136
12. Gabor F., Bogner E., Weissenboeck A., and Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Advanced Drug Delivery Reviews 56 (2004) 459-480
13. Nagata Y., and Burger M.M. Wheat-germ agglutinin - molecular characteristics and specificity for sugar binding. Journal of Biological Chemistry 249 10 (1974) 3116-3122
14. Wirth M., Fuchs A., Wolf M., Ertl B., and Gabor F. Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharmaceutical Research 15 7 (1998) 1031-1037
15. Clark M.A., Hirst B.H., and Jepson M.A. Lectin-mediated mucosal delivery of drugs and microparticles. Advanced Drug Delivery Reviews 43 2-3 (2000) 207-223
16. Lehr C.M., Bouwstra J.A., Kok W., Noach A.B.J., Deboer A.G., and Junginger H.E. Bioadhesion by means of specific binding of tomato lectin. Pharmaceutical Research 9 4 (1992) 547-553
17. Gabor F., Wirth M., Jurkovich B., Haberl I., Theyer G., Walcher G., and Hamilton G. Lectin-mediated bioadhesion: proteolytic stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes. Journal of Controlled Release 49 1 (1997) 27-37
18. Lavelle E.C., Grant G., Pusztai A., Pfuller U., and O'Hagan D.T. The identification of plant lectins with mucosal adjuvant activity. Immunology 102 1 (2001) 77-86
19. Adriaens E., and Remon J.P. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sexually Transmitted Diseases 35 5 (2008) 512-516
20. Hattori T., Hallberg R., and Dubin P.L. Roles of electrostatic interaction and polymer structure in the binding of beta-lactoglobulin to anionic polyelectrolytes: measurement of binding constants by frontal analysis continuous capillary electrophoresis. Langmuir 16 25 (2000) 9738-9743
21. Schmidt U., Zschoche S., and Werner C. Modification of poly(octadecene-alt-maleic anhydride) films by reaction with functional amines. Journal of Applied Polymer Science 87 8 (2003) 1255-1266
22. Salman H.H., Gamazo C., de Smidt P.C., Russell-Jones G., and Irache J.M. Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B-12-Gantrez nanoparticles. Pharmaceutical Research 25 12 (2008) 2859-2868
23. Liu S., Vareiro M.M., Fraser S., and Jenkins A.T. Control of attachment of bovine serum albumin to pulse plasma-polymerized maleic anhydride by variation of pulse conditions. Langmuir 21 19 (2005) 8572-8575
24. Estevan M., Irache J.M., Grillo M.J., Blasco J.M., and Gamazo C. Encapsulation of antigenic extracts of Salmonella enterica serovar - abortusovis into polymeric systems and efficacy as vaccines in mice. Veterinary Microbiology 118 1-2 (2006) 124-132
25. Ochoa J., Irache J.M., Tamayo I., Walz A., DelVecchio V.G., and Gamazo C. Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella enteritidis in mice. Vaccine 25 22 (2007) 4410-4419
26. Gomez S., Gamazo C., San Roman B., Ferrer M., Sanz M.L., and Irache J.M. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens. Vaccine 25 29 (2007) 5263-5271
27. Salman H.H., Gamazo C., Agueros M., and Irache J.M. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles. Vaccine 25 48 (2007) 8123-8132
28. Salman H.H., Gomez S., Gamazo C., Martins R.C., Zabaleta V., and Irache J.M. Micro-organism-like nanoparticles for oral antigen delivery. Journal of Drug Delivery Science and Technology 18 1 (2008) 31-39
29. Gogolak P., Rethi B., Hajas G., and Rajnavolgyi E. Targeting dendritic cells for priming cellular immune responses. Workshop on Cellular Transport Strategies for Targeting Epitopes Drugs and Reporter Molecules (2003), John Wiley & Sons Ltd., Budapest, Hungary 299-317
30. Xiang S.D., Scholzen A., Minigo G., David C., Apostolopoulos V., Mottram P.L., and Plebanski M. Pathogen recognition and development of particulate vaccines: does size matter?. Methods 40 1 (2006) 1-9